Back to peptide library

Advanced recovery blend

BPC-157 + TB-500 + KPV + GHK-Cu

Advanced multi-pathway recovery support for tissue repair, inflammatory balance, collagen support, immune signaling, and regeneration.

BPC tissue repairTB-500 systemic recoveryKPV inflammatory balanceGHK-Cu collagen support

The science

What is BPC-157 + TB-500 + KPV + GHK-Cu?

This advanced blend combines four complementary peptide categories into one coordinated recovery strategy.

BPC-157 supports localized tissue repair. TB-500 supports systemic recovery and tissue remodeling. KPV supports inflammatory and immune-signaling pathways. GHK-Cu supports collagen, tissue quality, skin, and regenerative support.

KPV is included only as a component inside this advanced blend. It is not listed as a standalone IPS Recovery option.

Ideal for

  • Patients whose goals match this protocol category
  • Recovery plans that require clinician review
  • Patients needing instructions, monitoring, and candidacy screening
  • Plans integrated with rehab, nutrition, sleep, and lifestyle strategy

Available through IPS

Clinical protocol context.

IPS reviews route, timing, candidacy, contraindications, tolerance, and protocol details privately during consultation. Public pages do not list dosing or pricing.

Advanced blend

BPC-157 + TB-500 + KPV + GHK-Cu

Advanced multi-pathway recovery blend reviewed privately during consultation.

KPV component

Not standalone

KPV is explained as part of this blend only.

Clinical role

Advanced recovery

Used when foundation recovery is not broad enough.

How it works

Mechanism and clinical use.

This page explains the core mechanisms and clinical focus areas without presenting a self-selection menu.

Local + systemic repair

BPC-157 and TB-500 support targeted and systemic recovery.

Inflammatory signaling

KPV supports inflammatory and immune-signaling pathways.

Collagen and regeneration

GHK-Cu supports collagen, elastin, tissue remodeling, and regenerative support.

Integrated recovery

Fits SoftWave, rehab, mobility, nutrition, and recovery planning.

Clinical benefits

Why IPS considers BPC-157 + TB-500 + KPV + GHK-Cu.

Benefits depend on patient goals, health history, protocol design, adherence, and response.

Multi-pathway strategySupports local repair, systemic recovery, inflammatory balance, immune signaling, collagen remodeling, and regeneration.
Tissue + collagen supportSupports connective tissue, tissue quality, and collagen production.
Complex recovery goalsUsed when foundational recovery support is not enough.
Simplified protocolCombines multiple recovery components into one strategy.

Process

How this works at IPS.

01

Consultation

Review goals, symptoms, medical history, medications, and current care.

02

Candidacy Review

Review contraindications, route, tolerance considerations, and clinical fit.

03

Custom Protocol

If appropriate, IPS reviews instructions, expectations, and follow-up timing.

04

Ongoing Care

Follow-ups evaluate tolerance, response, and next-step adjustments.

Questions

Frequently asked.

Is KPV available by itself?

No. KPV is only explained as a component inside this advanced blend.

Who is a good candidate?

Patients with complex recovery goals, inflammatory burden, collagen needs, post-injury recovery, or SoftWave-integrated recovery.

How is it administered?

When appropriate, IPS uses provider-guided subcutaneous protocols with patient-specific instructions.

What makes it different from BPC + TB-500?

It adds KPV for inflammatory/immune signaling and GHK-Cu for collagen and regenerative support.

Contact

Discuss BPC-157 + TB-500 + KPV + GHK-Cu with IPS.

Complete the form and IPS will follow up about consultation scheduling and next steps.

Send your details and IPS can follow up about consultation scheduling, eligibility, and next steps.

Medical noteThis educational page is not a diagnosis or treatment plan. Consultation and provider review are required.

Clinical sourcing note: IPS does not operate as a gray-market peptide source. Protocols are reviewed through a medical model with patient screening, candidacy review, provider oversight, and pharmacy-sourced products when prescribed. Peptides are not positioned as research-use-only products or self-directed online ordering.